Stockhub

Orphazyme A/S: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

26 September 2022

  • curprev 08:2408:24, 26 September 2022 95.149.241.133 talk 778 bytes +778 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative rare diseases. The company offers heat stock proteins that focuses on the treatment of neurodegenerative diseases by harnessing the cell protective properties of the heat shock response, which protects cells from the accumulation of misfolded proteins, aggregated proteins, and dysfunctional lysosomes. Its lead candidate is..."
Retrieved from "https://stockhub.co/research/Orphazyme_A/S"